La Via L, Marino A, Cuttone G, Nunnari G, Deana C, Tesauro M
Eur J Drug Metab Pharmacokinet. 2025; 50(2):105-118.
PMID: 39937350
PMC: 11882694.
DOI: 10.1007/s13318-025-00934-7.
Wolthuis D, Freriksen J, Ter Avest M, Kartha R, de Wildt S, Wijnsma K
Pediatr Nephrol. 2025; .
PMID: 39900743
DOI: 10.1007/s00467-025-06688-3.
Burkat P
J Psychopharmacol. 2025; 39(3):244-253.
PMID: 39754528
PMC: 11843794.
DOI: 10.1177/02698811241309620.
Ravichandran P, Pruskowski K
Eur Burn J. 2024; 4(4):573-583.
PMID: 39600026
PMC: 11571861.
DOI: 10.3390/ebj4040038.
Motovska Z, Hlinomaz O, Mrozek J, Kala P, Geisler T, Hromadka M
EuroIntervention. 2024; 20(20):e1309-e1318.
PMID: 39432252
PMC: 11472137.
DOI: 10.4244/EIJ-D-24-00203.
Evaluation of Vancomycin Dose Needed to Achieve 24-Hour Area Under the Concentration-Time Curve to Minimum Inhibitory Concentration Ratio Greater Than or Equal to 400 Using Pharmacometric Approaches in Pediatric Intensive Care Patients.
Jung D, Kishk O, Bhutta A, Cummings G, El Sahly H, Virk M
Crit Care Explor. 2024; 6(10):e1159.
PMID: 39352409
PMC: 11446596.
DOI: 10.1097/CCE.0000000000001159.
Sublingual asenapine for agitation in malabsorptive states: three patient cases.
Burk B, Humphreys K, Waites J, Adams B, Birur B, Parker P
Ther Adv Psychopharmacol. 2024; 14:20451253241263714.
PMID: 39070776
PMC: 11274017.
DOI: 10.1177/20451253241263714.
Antimicrobial Pharmacokinetic Considerations in Extracorporeal Membrane Oxygenation.
Johns K, Eschenauer G, Clark A, Butler S, Dunham S
J Clin Med. 2024; 13(12).
PMID: 38930083
PMC: 11204421.
DOI: 10.3390/jcm13123554.
Investigating clinical pharmacokinetics of brivaracetam by using a pharmacokinetic modeling approach.
Qayyum A, Zamir A, Rasool M, Imran I, Ahmad T, Alqahtani F
Sci Rep. 2024; 14(1):13357.
PMID: 38858493
PMC: 11164859.
DOI: 10.1038/s41598-024-63903-1.
Critical care pharmacy service provision and workforce in adult extracorporeal membrane oxygenation centres: a multicentre cross-sectional survey.
Remmington C, Cameron L, Hanks F, Liang Y, Barrow L, Coxhead R
Int J Clin Pharm. 2024; 46(4):854-861.
PMID: 38551749
DOI: 10.1007/s11096-024-01719-9.
Pharmacokinetics, pharmacodynamics, and safety of ciprofol emulsion in Chinese subjects with normal or impaired renal function.
Tao J, Liu S, Zhao Y, Qi L, Yan P, Wu N
Front Pharmacol. 2023; 14:1260599.
PMID: 38074142
PMC: 10704090.
DOI: 10.3389/fphar.2023.1260599.
Oral Drug Absorption and Drug Disposition in Critically Ill Cardiac Patients.
Harnisch L, Brockmoller J, Hapke A, Sindern J, Bruns E, Evertz R
Pharmaceutics. 2023; 15(11).
PMID: 38004576
PMC: 10674156.
DOI: 10.3390/pharmaceutics15112598.
Sustaining Life versus Altering Life-Saving Drugs: Insights to Explain the Paradoxical Effect of Extracorporeal Membrane Oxygenation on Drugs.
Abidi E, El Nekidy W, Atallah B, Al Zaman K, Ghisulal P, El Lababidi R
J Clin Med. 2023; 12(11).
PMID: 37297946
PMC: 10253730.
DOI: 10.3390/jcm12113748.
Adverse Drug Reactions Relevant to Drug Resistance and Ineffectiveness Associated with Meropenem, Linezolid, and Colistin: An Analysis Based on Spontaneous Reports from the European Pharmacovigilance Database.
Vintila B, Arseniu A, Butuca A, Sava M, Birlutiu V, Rus L
Antibiotics (Basel). 2023; 12(5).
PMID: 37237821
PMC: 10215571.
DOI: 10.3390/antibiotics12050918.
Potential pharmacological confounders in the setting of death determined by neurologic criteria: a narrative review.
Kanji S, Williamson D, Hartwick M
Can J Anaesth. 2023; 70(4):713-723.
PMID: 37131030
PMC: 10202973.
DOI: 10.1007/s12630-023-02415-4.
The Influence of Extracorporeal Membrane Oxygenation on Antibiotic Pharmacokinetics.
Peitz G, Murry D
Antibiotics (Basel). 2023; 12(3).
PMID: 36978367
PMC: 10044059.
DOI: 10.3390/antibiotics12030500.
The Use of Antibiotics and Antimicrobial Resistance in Veterinary Medicine, a Complex Phenomenon: A Narrative Review.
Caneschi A, Bardhi A, Barbarossa A, Zaghini A
Antibiotics (Basel). 2023; 12(3).
PMID: 36978354
PMC: 10044628.
DOI: 10.3390/antibiotics12030487.
Comparison of Anakinra and Tocilizumab in Anticytokine Therapy in the Treatment of Coronavirus Disease-2019.
Ozkan F, Sari S
Indian J Crit Care Med. 2023; 26(10):1091-1098.
PMID: 36876207
PMC: 9983662.
DOI: 10.5005/jp-journals-10071-24320.
Pharmacokinetic Alterations Associated with Critical Illness.
Castro D, Dresser L, Granton J, Fan E
Clin Pharmacokinet. 2023; 62(2):209-220.
PMID: 36732476
PMC: 9894673.
DOI: 10.1007/s40262-023-01213-x.
Meropenem population pharmacokinetics and model-based dosing optimisation in patients with serious bacterial infection.
Murinova I, Svidrnoch M, Gucky T, rezac D, Hlavac J, Slanar O
Eur J Hosp Pharm. 2022; 31(3):253-258.
PMID: 36307183
PMC: 11042353.
DOI: 10.1136/ejhpharm-2022-003535.